BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7828850)

  • 1. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.
    Welch PJ; Wang JY
    Genes Dev; 1995 Jan; 9(1):31-46. PubMed ID: 7828850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket.
    Whitaker LL; Su H; Baskaran R; Knudsen ES; Wang JY
    Mol Cell Biol; 1998 Jul; 18(7):4032-42. PubMed ID: 9632788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
    Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
    Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
    Sellers WR; Rodgers JW; Kaelin WG
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.
    Knudsen ES; Wang JY
    Mol Cell Biol; 1997 Oct; 17(10):5771-83. PubMed ID: 9315635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites.
    Knudsen ES; Wang JY
    J Biol Chem; 1996 Apr; 271(14):8313-20. PubMed ID: 8626527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F transcription factor is a target for the RB protein and the cyclin A protein.
    Nevins JR; Chellappan SP; Mudryj M; Hiebert S; Devoto S; Horowitz J; Hunter T; Pines J
    Cold Spring Harb Symp Quant Biol; 1991; 56():157-62. PubMed ID: 1840249
    [No Abstract]   [Full Text] [Related]  

  • 8. p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth.
    Birchenall-Roberts MC; Kim SJ; Bertolette DC; Turley JM; Fu T; Bang OS; Kasper JJ; Yoo YD; Ruscetti FW
    Oncogene; 1996 Oct; 13(7):1499-509. PubMed ID: 8875988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1.
    Harbour JW; Luo RX; Dei Santi A; Postigo AA; Dean DC
    Cell; 1999 Sep; 98(6):859-69. PubMed ID: 10499802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of distinct roles for separate E1A domains in disruption of E2F complexes.
    Ikeda MA; Nevins JR
    Mol Cell Biol; 1993 Nov; 13(11):7029-35. PubMed ID: 8413292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner.
    Shirodkar S; Ewen M; DeCaprio JA; Morgan J; Livingston DM; Chittenden T
    Cell; 1992 Jan; 68(1):157-66. PubMed ID: 1531040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.
    Wang S; Nath N; Minden A; Chellappan S
    EMBO J; 1999 Mar; 18(6):1559-70. PubMed ID: 10075927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function.
    Chen TT; Wang JY
    Mol Cell Biol; 2000 Aug; 20(15):5571-80. PubMed ID: 10891495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence.
    Alexander K; Hinds PW
    Mol Cell Biol; 2001 Jun; 21(11):3616-31. PubMed ID: 11340156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
    Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
    Rubin SM; Gall AL; Zheng N; Pavletich NP
    Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.
    Kim YW; Otterson GA; Kratzke RA; Coxon AB; Kaye FJ
    Mol Cell Biol; 1994 Nov; 14(11):7256-64. PubMed ID: 7935440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.